Report #2839267

Overview

Sex

Male

Age

63 yrs

State

MN

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

A 63 years old male patient received Priorix IM instead of subcutaneous; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of subcutaneous injection formulation administered by other route in a 63-year-old male patient who received MMR (Priorix) (batch number 82B72, expiry date 13-SEP-2026) for prophylaxis. On an unknown date, the patient received Priorix (intramuscular). On an unknown date, an unknown time after receiving Priorix, the patient experienced subcutaneous injection formulation administered by other route (Verbatim: A 63 years old male patient received Priorix IM instead of subcutaneous). The outcome of the subcutaneous injection formulation administered by other route was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 29-APR-2025 On 29th April 2025, a pharmacist had called to report that a 63 year old male patient had received Priorix intramuscularly instead of subcutaneously, which led to Subcutaneous injection formulation administered by other route. The pharmacist had stated that it had probably not reached the muscle completely because she had used a 5/8 inch needle.